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Conspectus
Nitrogen heterocycles are present in many compounds of enormous practical importance, ranging
from pharmaceutical agents and biological probes to electroactive materials. Direct functionalization
of nitrogen heterocycles through C-H bond activation constitutes a powerful means of
regioselectively introducing a variety of substituents with diverse functional groups onto the
heterocycle scaffold. Working together, our two groups have developed a family of Rh-catalyzed
heterocycle alkylation and arylation reactions that are notable for their high level of functional-group
compatibility. This Account describes our work in this area, emphasizing the relevant mechanistic
insights that enabled synthetic advances and distinguished the resulting transformations from other
methods.
We initially discovered an intramolecular Rh-catalyzed C-2-alkylation of azoles by alkenyl groups.
That reaction provided access to a number of di-, tri-, and tetracyclic azole derivatives. We then
developed conditions that exploited microwave heating to expedite these reactions. While
investigating the mechanism of this transformation, we discovered that a novel substrate-derived Rh-
N-heterocyclic carbene (NHC) complex was involved as an intermediate. We then synthesized
analogous Rh–NHC complexes directly by treating precursors to the intermediate [RhCl(PCy3)2]
with N-methylbenzimidazole, 3-methyl-3,4-dihydroquinazoline, and 1-methyl-1,4-
benzodiazepine-2-one.
Extensive kinetic analysis and DFT calculations supported a mechanism for carbene formation in
which the catalytically active RhCl(PCy3)2 fragment coordinates to the heterocycle before
intramolecular activation of the C-H bond occurs. The resulting Rh-H intermediate ultimately
tautomerizes to the observed carbene complex. With this mechanistic information and the discovery
that acid co-catalysts accelerate the alkylation, we developed conditions that efficiently and
intermolecularly alkylate a variety of heterocycles, including azoles, azolines, dihydroquinazolines,
pyridines, and quinolines, with a wide range of functionalized olefins. We demonstrated the utility
of this methodology in the synthesis of natural products, drug candidates, and other biologically
active molecules.
In addition, we developed conditions to directly arylate these heterocycles with aryl halides. Our
initial conditions that used PCy3 as a ligand were successful only for aryl iodides. However, efforts
designed to avoid catalyst decomposition led to the development of ligands based on 9-
phosphabicyclo[4.2.1]nonane (Phoban) that also facilitated the coupling of aryl bromides. We then
replicated the unique coordination environment, stability, and catalytic activity of this complex using
the much simpler tetrahydrophosphepine ligands and developed conditions that coupled aryl
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bromides bearing diverse functional groups without the use of a glovebox or purified reagents. With
further mechanistic inquiry, we anticipate that researchers will better understand the details of the
aforementioned Rh-catalyzed C-H bond functionalization reactions, resulting in the design of more
efficient and robust catalysts, expanded substrate scope, and new transformations.
Introduction
Nitrogen heterocycles are present in many compounds of enormous practical importance,
ranging from pharmaceutical agents and biological probes to electroactive materials. Tailoring
the properties of these compounds to satisfy their specific functions necessitates the
development of synthetic methods capable of regioselectively introducing a variety of
substituents bearing diverse functional groups to the desired heterocycle scaffold. Direct
functionalization of nitrogen heterocycles through C-H bond activation constitutes a powerful
means to accomplish this important goal.1
This approach provides an atom-economical alternative to conventional procedures using
halogenated or metallated starting materials.2 However, a potential catalyst must activate a
relatively inert C-H bond in the presence of other C-H bonds and then efficiently functionalize
the metallated carbon in order to provide the desired product.3 Despite these demanding
requirements, a number of reactions that exploit directing groups,4 repulsive steric interactions,
5 electron-rich substrates,6 C-H bond acidity,7 radical stability8, and even enzymes9 to
selectively activate and functionalize a specific C-H bond with a transition metal catalyst have
been developed. When applicable to a particular substrate class, these methods reduce reaction
byproducts, increase the number of available substrates, and decrease the synthetic effort
required for formation of the desired C-C bond.
Selecting the appropriate catalyst for a desired substrate can seem daunting. However,
understanding the mechanisms of the individual transformations provides a rational approach
to addressing this problem as well as a framework for the application and continued discovery
of new transformations. Working together, principally via jointly supervised coworkers, our
two groups have extensively applied this strategy toward the development of a family of Rh-
catalyzed heterocycle alkylation and arylation reactions that are notable for the high level of
functional group compatibility that is achieved. This account describes our work in this area,
emphasizing the relevant mechanistic insights that enabled synthetic advances and
distinguished the resulting transformations from other methods.
Intramolecular Alkylation of Azoles
The prevalence of 2-alkyl azoles in drugs led to our interest in developing a catalytic method
for the alkylation of azoles at the 2-position.10 At the time we began our investigations in this
area, a number of researchers had demonstrated the feasibility of directly arylating the 2-
position of azoles with aryl halides using Pd catalysis11 and acylating this same site using Ru
catalysis.12 We envisioned that the analogous alkylation reaction might be accomplished by
formal hydroheteroarylation of an olefin by an azole in the presence of a transition metal
catalyst.13
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A number of late transition metal complexes were screened for their ability to catalyze the
intramolecular alkylation of a benzimidazole bearing a pendant olefin, which led to the finding
that Wilkinson’s catalyst (RhCl(PPh3)3) provided a single cyclization product 1 in 60% isolated
yield (Scheme 1). Optimization of the reaction parameters led to the identification of [RhCl
(coe)2]2 (coe = cyclooctene) as a highly effective Rh pre-catalyst and PCy3 as the optimal
phosphine. This catalyst system was then applied toward the synthesis of a range of bi-, tri-,
and tetracyclic 2-alkylimidazoles (Scheme 2, conditions a). In general, the cyclization provides
products containing a five-membered ring as the major isomer unless an overriding steric bias,
such as geminal alkene substitution or allylic α,α-dibranding, prevails. This preference is
observed for both allyl- and homoallyl-substituted imidazoles due to rapid, competitive olefin
isomerization that generates an allyl-substituted cyclization precursor regardless of the initial
olefin position.
Extensive efforts to improve the efficiency of this reaction led to the discovery that Lewis and
Brønsted acid additives, including 2,6-dimethylpyridinium chloride and magnesium bromide,
provided marked increases in reaction rate and conversion.14 It was subsequently found that
[PCy3H]Cl could be conveniently utilized to provide both the additive and the phosphine. This
modification simplifies the reaction setup and renders the phosphine air stable for long-term
storage.
In a collaborative effort with researchers at Abbott Laboratories, the cyclization reactions
described above were reinvestigated using [PCy3H]Cl and a simplified protocol employing
microwave heating (Scheme 2, conditions b).15 The use of a microwave reactor allows
convenient access to the high temperatures needed to reduce reaction times to ≤ 20 min, and
the initial reaction mixtures were assembled using only a N2 line to degas the solvent and
reaction vessel prior to heating.16 A microwave procedure was also developed using
commercially available Wilkinson’s catalyst in place of [RhCl(coe)2]2/PCy3. Even with this
suboptimal catalyst, the desired cyclized products were obtained in moderate yields (data not
shown).
The intramolecular alkylation reaction has subsequently been applied to the synthesis of
complex bioactive compounds. For example, the potent c-Jun N-terminal kinase inhibitor 3,
originally prepared in 14 linear steps and 6% overall yield,17 was prepared in 11 linear steps
and 13% overall yield by relying on our C-H functionalization reaction as the key step in the
sequence (Scheme 3).18 More highly substituted derivatives 4, ent-4, and 5, which would be
very difficult to prepare by alternative methods, could be readily synthesized just as rapidly in
15 and 17% overall yields, respectively, and resulted in the identification of even more potent
inhibitors (Figure 1).
Investigation of the Mechanism of C-H Activation
Having established the utility of this new method for the intramolecular alkylation of
imidazoles, we undertook an investigation of the mechanism of this novel transformation.19
Initial deuterium tracer and crossover experiments revealed that rapid H/D exchange occurred
between the heterocycle 2-position and pendant and external olefins. In order to shed further
light on this exchange and to minimize the number of concurrent processes, the non-
isomerizable substrate 6 was heated in the presence of stoichiometric quantities of [RhCl
(coe)2]2 and PCy3 at a temperature substantially below that required for cyclization in the
absence of acid co-catalysts (Scheme 4).
A single compound, assigned as the square planar Rh(I)-N-heterocyclic carbene (NHC)
complex 7 by X-ray crystallography (Figure 2), formed under these conditions. This result was
surprising, given that literature precedent generally indicates the formation of Rh(III)- or Ir
(III)-hydride complexes following C-H bond activation by neutral Rh(I) or Ir(I) species.3
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Nonetheless, 7 catalyzed the cyclization of benzimidazole derivative 8 at the same rate as [RhCl
(coe)2]2/PCy3 (Scheme 5). Furthermore, a kinetic investigation of the cyclization of 8 catalyzed
by complex 7 indicated that the reaction was zero order in [8] and first order in [7]. These
results are consistent with a mechanism in which the resting state of the catalyst contains a
single molecule of bound substrate. Carbene complex 7 forms at a lower temperature than that
at which cyclization occurs and is observed throughout the reaction, leading to the conclusion
that 7 is the resting state of the catalyst.
Similar Rh-NHC complexes have been obtained from the reaction of [RhCl(coe)2]2 and
PCy3 with a number of additional heterocycles, including benzimidazole,20 3,4-
dihydroquinazoline,21 and a 1,4-benzodiazepine-2-one22 (Scheme 6, Figure 3). Prior to these
examples, the direct formation of metal-NHC complexes from the corresponding heterocycles
had not been reported. The novelty of this transformation, in addition to its centrality to our
alkylation chemistry, led us to explore its mechanism in greater detail.
Closer examination of the reaction of 3-methyl-3,4-dihydroquinazoline 13, [RhCl(coe)2]2, and
PCy3 at 45 °C in THF revealed the initial formation of a N-bound Rh-heterocycle complex,
14 (Scheme 7).21 The structure of this complex was established unambiguously by extensive
multi-dimensional NMR experiments on a variety of 2H, 13C, and 15N labeled 3-methyl-3,4-
dihydroquinazolines. Upon further heating at 75 °C, this material was converted to the Rh-
NHC complex 11. Careful kinetic analysis established the N-bound complex 14 as an
intermediate in the formation of 11.
Deuterium labeling tracer experiments using C2-D-14 led to formation of the carbene complex
possessing 88% deuterium at the N1 position. In addition, a double-labeling crossover
experiment carried out using equal amounts of C2-D-13 and 15N1-13 revealed only a minor
amount of crossover product (14N1-H-11/15N1-D-11). Together, these data are consistent with
an intramolecular H-transfer in the conversion of 14 to 11. The deuterium kinetic isotope effect
on rate of conversion of 14 to 11 was measured, and the observed kH/kD (1.8 ± 0.1) is consistent
with cleavage of the C2-H bond during or prior to the rate limiting step. Activation parameters
(ΔH‡ = 26.0 ± 0.3 kcal/mol and ΔS‡ = −10.3 ± 0.8 cal/mol·K) were also obtained and reveal
the dramatic extent to which metal-mediation facilitates heterocycle-to-NHC tautomerization.
In an effort to gain further insight into the microscopic steps of C-H activation, these detailed
mechanistic data were augmented with DFT calculations. A model system using 3-methyl-3,4-
dihydropyrimidine in place of 13 and PMe3 in place of PCy3 was constructed based upon the
structures of 14 and 11. Conversion of starting complex A, the structure of which is in
agreement with all spectroscopic data for 11, to I was most consistent with a mechanism shown
in Figure 4. Importantly, this mechanism indicated that the aforementioned Rh(III)-hydride
complex (G in Figure 4) does indeed lie on the reaction coordinate, but that the NHC tautomer
is thermodynamically more stable and readily accessible via an intermolecular H migration.
While N-heterocyclic carbenes are commonly utilized as ancillary ligands on transition metal
complexes,23 the results highlighted above marked the first time that such complexes had been
implicated as intermediates in a catalytic reaction.24 More significantly, the known formation
of stable metal-NHC complexes derived from myriad metals and carbene precursors, most
notably azoles,23 non-aromatic heterocycles,25 heterocycles with only a single heteroatom,
26 and even certain acyclic molecules,27 suggested that a number of additional substrates might
also be compatible with Rh-catalyzed alkylation reaction conditions. Taken together with our
synthesis of metal-NHC complexes directly from a variety of heterocycles, these precedents
provided strong evidence that a greatly expanded substrate scope of Rh-catalyzed alkylation
could be realized.
Lewis et al. Page 4
Acc Chem Res. Author manuscript; available in PMC 2009 August 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Intermolecular Alkylation of Heterocycles
Azoles
Initial efforts to achieve this goal focused on the intermolecular alkyation of various azoles
with alkenes. Reaction conditions were initially evaluated for the intermolecular alkylation of
benzimidazole using 3,3-dimethyl-1-butene which proceeded efficiently with catalytic
amounts of [RhCl(coe)2]2 and either [PCy3H]Cl or PCy3 and 2,6-dimethylpyridinium chloride
(LutCl) (Scheme 8).14 Heterocycles capable of stabilizing M-NHC complexes served as
effective substrates, including 1-methylbenzimidazole, benzthiazole, benzoxazole, 4,5-
dimethylthiazole, and purine. Moreover, a broad functional group tolerance on the heterocycle
was observed, and a variety of terminal olefins were compatible with the reaction conditions.
In particular, both electron rich and electron poor olefins underwent coupling efficiently, and
numerous functional groups, including silyl ethers, esters, acetals, phthalimides, and nitriles
were tolerated.
3,4-Dihydroquinazolines
Quinazoline-derived metal-carbene complexes are less well represented in the literature than
their azole congeners, but the results of our study of complex 11 provided ample motivation
to explore the Rh-catalyzed alkylation of this heterocycle class.28 Furthermore, the quinazoline
skeleton, in its various oxidation states, is a common structural motif in natural products and
pharmaceuticals with a range of biological activities.29 We initially investigated the alkylation
of 3,4-dihydroquinazoline because it can be readily converted to the analogous quinazolines,
quinazolinones, or 1,2,3,4-tertahyrdroquinazolines by choice of an appropriate oxidant or
reductant.30
Analysis by 1H NMR spectroscopy established that quantitative C2 alkylation of 3,4-
dihydroquinazoline occurred with n-hexene in the presence of our Rh catalyst. To simplify
product analysis, oxidation of the crude alkylation product to the corresponding alkylated
quinazoline was accomplished using MnO2 (Scheme 9). In contrast to the azole alkylation
discussed above, both styrene and methylenecyclohexane, a 1,1-disubstituted alkene, coupled
efficiently, and N-methyldihydroquinazoline also proved to be a viable substrate.
Intramolecular dihydroquinazoline alkylation is also of interest because the process can be
used to form ring-fused pyrrolo[2,1-b]quinazolines, a common scaffold for medically relevant
natural products.29 To demonstrate the applicability of this method, we undertook a total
synthesis of vasicoline (Scheme 10). Cyclization of 15 proved to be particularly challenging,
but a conformationally rigid cyclohexyl-phoban ligand, which had previously provided
ruthenium alkylidene catalysts with enhanced stability,31 proved to be an effective ligand to
facilitate the desired reaction.
Azolines
Non-aromatic azolines were next targeted as potential substrates since the wealth of literature
on azoline-derived carbene ligands suggested that the corresponding azolines should be
compatible with our NHC mechanism.25 We were particularly interested in the alkylation of
oxazolines as such a method would constitute a formal C1 olefin homologation without the
use of toxic CO gas. The alkylated oxazolines could subsequently be converted to carboxylic
acids or esters using well-known chemistry.32
Alkylation of 4,4-dimethyl-2-oxazoline was achieved with a large number of alkenes
displaying a range of functionality in the presence of our Rh-phosphine catalyst (Scheme 11).
33 Under optimal conditions the alkylation could often be performed at 45 °C, a temperature
significantly lower than that used in the coupling of aromatic azoles. Both 1,1- and 1,2-
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disubstituted alkenes were effective coupling partners, and cyclohexene and
methylenecylcohexane underwent coupling with good to moderate yield. Even α-
methylstyrene, which results in a new stereocenter, coupled with modest efficiency.
Pyridines
In all of the substrates compatible with the Rh-catalyzed alkylation chemistry discussed thus
far, the reactive carbon atom is flanked by two heteroatoms. This motif presumably stabilizes
the proposed Rh-NHC intermediates common to this family of reactions.23 However, a number
of groups have investigated the formation of NHC complexes in which two donating
heteroatoms are not required.26,27 While these complexes were not necessarily formed via
the activation of a C-H bond, they did indicate the possibility that such complexes could
function as catalytic intermediates. The Carmona and Esteruelas groups recently reported the
synthesis of 2-substituted-pyridine- and quinoline-based Os, Ru, and Ir-NHC complexes
directly from the corresponding heterocycles and a late transition metal complex.26 The
authors propose mechanisms similar to those shown in Figure 4, but emphasize the necessity
of substitution ortho to the heterocycle ring nitrogen in order to drive the equilibrium from an
N-bound to the desired NHC complexes (Scheme 7, Figure 4). We therefore sought to
determine whether our Rh/PCy3 catalyst system could be used to not only activate but also
alkylate these heterocycles.
Slight modifications to the conditions optimized for azole alkylation enabled the alkylation of
a number of 2-substituted pyridines (Scheme 12).34 Increasing the bulk of the 2-substituent
from methyl to isopropyl led to an increase in both alkylation rate and isolated yield of alkylated
product, and 2-triisopropylsilylpyridine also proved to be an effective substrate. Consistent
with the findings of Carmona and Esteruelas for carbene formation,26 pyridine was alkylated
in less than 5% yield when heated in the presence of excess olefin and catalyst.
A variety of quinolines were also alkylated under the reaction conditions. Parent quinoline was
nearly quantitatively converted to the corresponding alkylated quinoline, and both ether and
ester substitution were tolerated in the quinoline 6-position. A wide range of olefin substitution
patterns were also compatible with the reaction conditions.
While substitution ortho to the pyridine nitrogen was required to obtain high yields of alkylated
products, an ortho-silyl group serves as a suitable blocking group that can readily be removed
to provide mono-alkylated pyridines. For example, treatment of 18 with aqueous HF in
refluxing THF provided the mono-alkylated pyridine product 19 in good yield (Scheme 13).
In a preliminary evaluation of catalyst loading, quinoline was alkylated with neohexene in 91%
yield using only 0.5 mol% of the Rh catalyst (Scheme 14).
Rh-Catalyzed Direct Arylation of Heterocycles
Our successes in the area of Rh-catalyzed heterocycle alkylation led us to postulate the
feasibility of the corresponding arylation, as such a transformation would provide a highly
efficient route to pharmaceutically relevant compounds.35 At the time we began our research
in this area, direct heterocycle arylation had seen only limited literature precedent with
Miaura’s pioneering work using Pd catalysis as the most notable example.11 Furthermore, we
hoped that the novel mode of activation available using Rh-catalysis might offer
regioselectivity and substrate scope different from those observed with existing Pd and Cu-
based catalysts.36
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Discovery and Optimization of Rh-Catalyzed Heterocycle Arylation
Aryl iodides were identified as suitable coupling partners for the arylation of benzimidazole
using catalytic amounts of [RhCl(coe)2]2 and PCy3 in the presence of triethylamine (Scheme
15).20 In promising initial studies, a range of heterocycles, including benzimidazoles,
benzoxazoles, 3,4-dihydroquinazoline and 3,3-dimethyl oxazoline, and both electron-rich and
poor aryl halides coupled in moderate to good yields.
In addition, hydrodehalogenation of the aryl iodide coupling partner was identified as a key
side reaction under the reaction conditions.37 This process resulted from the dehydrogenation
of the cyclohexyl groups of PCy3, which led to the formation of reactive Rh-hydride complexes
and ligand decomposition.38 Our efforts to find phosphines that would maintain the unique
steric and electronic qualities of PCy3, while reducing the ability of the phosphine to undergo
dehydrogenation, led to the exploration of P-substituted phobanes as used for the previously
discussed dihydroquinazoline alkylation (Figure 5).28 Superior results were obtained using
the [4.2.1] phoban isomers (22a and 22b) as opposed to the [3.3.1] isomer (21) used in the
alkylation reaction.
Microwave heating was employed to facilitate reaction set-up and to conveniently reach the
higher temperatures needed to minimize reaction time. Following optimization of the reaction
conditions, 2-phenylbenzimidazole was produced from the coupling of benzimidazole and
iodobenzene in a 95% yield. More importantly, bromobenzene was also coupled to
benzimidazole in 80% isolated yield under the same reaction conditions (Scheme 16).
The direct arylation of heterocycles with aryl bromides using a Rh/22a/b catalyst exhibited
considerable functional group tolerance39 and provided access to 2-arylbenzimidazoles
incorporating a wide variety of functional groups, including nitrile, chloride, alkoxy, ketone,
and amide substituents (data not shown). The reaction conditions were compatible with a
number of different heterocycles, including N-methylbenzimidazole, benzoxazole, 3,4-
dihydroquinazoline and bis-arylimidazoles.
Development of New Ligands
Efforts to understand the enhanced arylation activity afforded through the use of 22a/b revealed
the formation of P-olefin complex 23 under the arylation reaction conditions (Scheme 17).40
This complex was prepared in good yield, and its structure was confirmed by single crystal X-
ray analysis (Figure 6). The structure clearly showed that one of the ligands had been selectively
dehydrogenated to generate a P-olefin binding motif, while the second was left intact. The
stability of this complex even under extended heating at 125 °C indicated the existence of
tighter chelation of the rhodium center relative to the analogous complex formed in situ from
Rh/PCy3, which underwent multiple rounds of cyclometallation/β-hydride elimination
ultimately leading to complete decomposition.
Complex 23 catalyzed the arylation of benzimidazole with a rate and final yield similar to those
obtained with the use of [RhCl(coe)2]2/22a/b. Thus, the capacity of 22a/b to form a stable
bidentate P-olefin Rh complex, and not solely the sterics and electronics of the phosphines
themselves, is largely responsible for the superior activity of the arylation catalysts derived
from phobane ligands. Based on this hypothesis, we sought to simplify the phosphine ligand
while maintaining the P-olefin binding motif that conferred the unique activity of 23 through
the use of (Z)-2,3,6,7-tetrahydrophosphepines (Figure 7).41
A family of these ligands was synthesized, and the Rh complex (27) of (Z)-1-
cyclohexyl-2,3,6,7-tetrahydro-1H-phosphepine (25) was prepared (Scheme 18). The structure
of 27 was confirmed by single crystal X-ray analysis (Figure 8). Notably, the Rh-binding motifs
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found in 23 and 27 exhibited a great deal of similarity, indicating that removing the 2-carbon
bridge from 22a did not significantly alter the desired coordination geometry.
The tert-butyl-substituted phosphepine 28 (Figure 7, R = t-Bu) provided the highest conversion
and and essentially no hydrodehalogenation of PhBr during the course of the arylation of
benzimidazole, with optimal conditions being microwave heating at 200 °C for 2 h with THF
as the solvent.42 The unique reactivity of these ligands compared with those previously
investigated suggests that the hemi-labile P-olefin coordination modulates the reactivity of the
Rh center to allow the desired heterocycle arylation while reducing off-cycle
hydrodehalogenation. At this point we do not have very much information about the mechanism
of the arylation reaction, compared to the progress that has been made in the alkylation reactions
discussed earlier in this article. However, if N-heterocycle carbene intermediates are also
involved in the arylation, a reasonable hypothesis for the mechanism of the overall process is
illustrated in Scheme 19. In this context, the Rh(I)-NHC intermediate is particularly attractive,
since the low oxidation state at Rh prepares the metal center for oxidative addition of an aryl
halide. However, further mechanistic investigation will be required to determine whether the
mechanisms of the alkylation and arylation reactions do proceed by analogous pathways.
Substrate Scope of Heterocycle Arylation Using Rh-Phosphepine Catalyst 28
The optimized reaction conditions exhibited very high functional group tolerance, and allowed
the use of aryl halides and heterocycles containing acidic NH and OH groups that have yet to
be demonstrated as viable azole direct arylation substrates using Pd or Cu catalysis (Scheme
20).36 In particular, sulfinyl, chloro, acetamide, free hydroxy, and free amine groups were all
tolerated; however, ortho substitution was not. Electron rich heteroaryl bromides, including 5-
bromo-1-methylindole, 5-bromobenzoxazole, 5-bromobenzothiazole, and 3-bromothiophene,
also underwent coupling in excellent yields. These results are particularly notable given that
these heterocycles undergo electrophilic metallation by Pd catalysts, which could cause
regioselectivity problems in Pd-catalyzed direct arylations using these substrates.43
A variety of additional heterocycles were also compatible with the Rh-catalyzed arylation
conditions. Unprotected N-H benzimidazoles were optimal, N-methylbenzimidazole and
benzoxazole coupled in good yield, and benzthiazole was a viable substrate. Pharmaceutically
important bisarylimidazoles were also excellent arylation substrates, and both indolyl- and
pyridyl-subsitution, common to a number of known drug candidates, can be present on the
imidazole ring.44 Finally, arylation of 4,5-dimethylthiazole and the non-aromatic 4,4-
dimethyloxazoline provided moderate yields of the corresponding arylated products.
The arylation protocol was greatly simplified through the use of [28H]BF4, an air-stable
surrogate of 2845 that is now commercially available from Sigma-Aldrich, and [RhCl(cod)]2
(cod = cyclooctadiene), a much less expensive, air-stable Rh source (Scheme 21). Using these
catalyst precursors, the reaction mixtures can be assembled without the use of a glovebox and
purified reagents and with only a N2 line to provide an inert atmosphere in the microwave
vessel. In general, high yields of the desired products were obtained using standard lab
equipment, so it is anticipated that these conditions would be most suitable for practical
applications. Comparable results were obtained with dioxane as solvent (data not shown).
Preliminary investigation of catalyst loading was also performed under conventional heating,
which is most applicable to large-scale reactions. At 1% loading of the [RhCl(coe)2]2
precatalyst in dioxane at 175 °C, a high yield of arylation product was obtained within 24 h
(Scheme 22).
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Summary and Outlook
In summary, we have used mechanistic insight to guide the development of efficient, functional
group tolerant Rh-catalyzed heterocycle alkylation and arylation reactions. This work
commenced with the identification of an intramolecular azole alkylation catalyzed by a Rh(I)-
phosphine complex. The discovery that this reaction proceeds via a Rh-NHC intermediate
inspired the extension of this reaction to the intermolecular alkylation of a variety of substrates
compatible with this intermediate, including azoles, azolines, 3,4-dihydroquinazolines,
pyridines, and quinolines.
We then hypothesized that this electron-rich low-valent Rh(I) complex might also be ideally
suited to affect the oxidative addition step required in the corresponding heterocycle arylation.
Indeed, methods for coupling aryl iodides and ultimately aryl bromides to the previously
mentioned heterocycles were developed. These methods were notable in the extremely high
functional group tolerance and unique selectivity compared to Cu- and Pd-catalyzed methods.
Further mechanistic inquiry will lead to an increased understanding of the intimate details of
the aforementioned Rh-catalyzed C-H functionalization reactions enabling the design of more
efficient and robust catalysts. Moreover, many additional classes of nitrogen heterocycles
should be capable of undergoing C-H bond activation to provide NHC-metal intermediates,
and it is likely that this important new pathway for C-H bond activation will make possible
new catalytic C-H bond functionalization methods.
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Figure 1.
Methylated Derivatives of Kinase Inhibitor 3.
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Figure 2.
ORTEP Diagram of 7.
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Figure 3.
ORTEP Diagrams of 10–12.
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Figure 4.
Calculated Reaction Coordinate for Carbene Formation.
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Figure 5.
Structures of [3.3.1] (21), exo-[4.2.1] (22a), and endo-[4.2.1] (22b) Isomers of 9-Cyclohexyl-9-
phosphabicyclononane.
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Figure 6.
ORTEP diagram of 23.
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Figure 7.
(Z)-2,3,6,7-Tetrahydrophosphepine skeleton.
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Figure 8.
ORTEP Diagram of 27.
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